Chemours Expands Access to Market-leading Opteon™ XP40 in European Union in Support of F-Gas Phasedown

WILMINGTON, Del., May 30, 2018 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that it has signed a distributor agreement with Arkema for the distribution of XP40 (R-449A) in the European Union to meet the growing demand for low global warming potential (GWP) refrigerants under the F-Gas Regulation.

The 2018 F-Gas cap and phasedown reduction of 37% has generated significant demand for low GWP alternatives to replace legacy products such as R-404A/R-507A.  XP40 is currently the refrigerant of choice among leading supermarkets, retailers, contractors, distributors and end-users in the EU for retrofit and new equipment, delivering improved performance with a more sustainable environmental footprint and over 65% reduction in GWP vs. existing products.

With this agreement, Chemours is bringing this key product to even more customers in the marketplace.  "We are pleased to be able to expand the access of XP40 in the EU market via Arkema, another leading supplier of fluorochemical refrigerants," said Diego Boeri, vice-president of Chemours Fluorochemicals. "Since 2015, XP40 has played a critical role in allowing the market to comply with the F-Gas Regulation.  We are committed to continuing to help the industry succeed under the F-Gas Regulation while enabling customers and the marketplace to ensure business continuity."

Chemours is proud to offer a full portfolio of low and very low GWP solutions to enable customers to meet their F-Gas objectives.  Along with XP40, Opteon™ XL products are very low GWP solutions offering up to 99% GWP reduction and improved performance for new equipment designs.

For more information visit opteon.com

About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing.  Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe. 

Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com, or follow us on Twitter @Chemours, or LinkedIn.   

Forward Looking Statements
This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "anticipate," "target," "project," and similar expressions, among others, generally identify "forward-looking statements" which speak only as of the date the statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, litigation and other legal proceedings or contingencies, anticipated future operating and financial performance, business plans and prospects, transformation plans, cost savings targets and plans to increase profitability, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties which are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2017. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACT:

NEWS MEDIA
Maria Chacon
Sr. Global Marketing Communication Manager, Fluorochemicals
+1 302-773-4510
[email protected]  

INVESTORS
Jonathan Lock
VP, Corporate Development and Investor Relations
+1.302.773.2263
[email protected]

SOURCE The Chemours Company